- This event has passed.
Innovation through collaboration
December 2, 2021 @ 9:30 am - 10:30 am
Europe is an established leader in innovation (R&I), delivering major advances in health research, with investment in medtech R&D in Ireland growing. The annual European Innovation Scoreboard shows that amid increased innovation performance across the EU, Ireland remains a Strong Innovator and, in 10th place, remains one of the top ten most innovative Member States, performing above the EU average. Ireland must embrace a new approach to unlocking competitive advantage. With tax and regulation advantages under pressure, and increased competition for the required talent, new differentiators must be exploited. We must unlock a new formula for advantage, built upon collaboration, innovation and capability.
Innovation is at the heart of the medtech sector, and medtech is perhaps the most innovative sector, with over 14,000 patents filed in the EU last year. A thriving R&D ecosystem that can continuously reinvent itself is critical. Becoming a centre of excellence for R&D and winning more corporate R&D portfolios is a strategic objective under the Irish Medtech Association Strategy to 2020. As such, the Irish Medtech Association commissioned research to support the development of a strategy to increase the R&D intensity of the Irish medtech sector. The decision on the location factors for R&D is driven by the interplay of various factors, that can be classified into three groups; parent company strategies, subsidiary potential and host country characteristics. In this session, the panellist will discuss the ecosystem required to support a thriving innovation base, and how the ability to collaborate can position Ireland as a location where ideation can blossom, and where FDI can continuously win not only more sophisticated R&D. Globalization of R&D and opportunities to increase the ambition and level medtech R&D in Ireland.
Chair: Anton Savage, Journalist
- Julie Byrne: Global Head of Nokia Bell Labs External Collaboration Programs, Chair of the Government Advisory Committee on Creating Our Future
- Peter Walsh, CEO, Slo Consulting
- Michael Keane, Director of New Products Development, Boston Scientific